Cancer News and Research

Latest Cancer News and Research

Childhood cancer survivors 5 times more likely to get cancer again: Study

According to a new study, children who survive cancer are at a higher risk of cancer later in life or may die early of other cause. The study included almost 900 young cancer survivors treated at Sydney Children's Hospital, from 1972 to 1999, alongside new cancer cases and early deaths. The risk of cancer was five times higher in childhood cancer survivors, the results showed, compared with the overall NSW population, that these survivors were seven and a half times more likely to die early.

5 Sep 2010

New insight into abnormalities in cancer cells

A basic requirement for growth and life of a multicellular organism is the ability of its cells to divide. Chromosomes in the cells duplicate and are then distributed among the daughter cells. This distribution is organized by a protein complex made up of several hundred different proteins, called the centrosome. In cancer cells, the centrosome often assumes an unnatural shape or is present in uncontrolled numbers. The reasons for this were previously largely unknown.

4 Sep 2010

Researchers to study protein fragments released into bloodstream after heart attack

A blood test to diagnose which heart attack survivors will suffer heart failure is the goal of a new five-year, $11.6 million contract to the UT Health Science Center San Antonio from the National Heart, Lung, and Blood Institute (NHLBI).

4 Sep 2010

Study suggest PET/CT scanning may offer effective breast cancer detection, spread

About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread. Controversy continues to surround the question of whether CT and bone scans should be standard in evaluating patients for these metastases, or whether integrated PET/CT scanning might be more effective at detecting breast tumors that have reached nearby bones.

4 Sep 2010

Genetic predisposition reduces breast, ovarian cancer risk with preventive surgeries: Study

A long-term study of women with a genetic predisposition for breast or ovarian cancer showed that those who elected major preventive surgeries had a significantly reduced risk of those cancers.

4 Sep 2010

MSKCC develops new prediction tool to calculate risk for DCIS recurrence after breast-conserving surgery

The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.

4 Sep 2010

Exelixis grants 25,200 shares to nine new employees

Exelixis, Inc. announced that today it granted restricted stock units representing an aggregate of 25,200 shares of Exelixis common stock to nine new employees.

4 Sep 2010

Research on iPS cells can imply potential cell therapy for X-linked disorders

Female induced pluripotent stem (iPS) cells, reprogrammed from human skin cells into cells that have the embryonic-like potential to become any cell in the body, retain an inactive X chromosome, stem cell researchers at UCLA have found.

4 Sep 2010

Researchers complete INX-189 clinical trials for Hepatitis C virus

The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed.

3 Sep 2010

CyberKnife radiosurgery treatment effective for prostate cancer without side effects

CyberKnife radiosurgery treatment for prostate cancer is rapid, effective and has no side effects, with the added benefit of being non-invasive.

3 Sep 2010

CSI Laboratories to expand new diagnostic laboratory in Alpharetta

CSI Laboratories, a private national cancer diagnostic laboratory, today announced the lease of a new 65,000 square foot facility in Alpharetta, GA, located north of the city of Atlanta.

3 Sep 2010

Study finds acupuncture can control side effects of cancer treatment

Recent studies have shown that acupuncture can help control a number of symptoms and side effects such as pain, fatigue, dry mouth, nausea, and vomiting associated with a variety of cancers and their treatments.

3 Sep 2010

More support needed for erectile dysfunction says sexologist

According to sexologist Bettina Arndt, there are thousands of Australian men with erectile dysfunction who are sexually impotent because of their condition and the lack of affordable treatments. Arndt said that funds distribution for breast prostheses for female cancer patients is one of the examples of mismatches in funding.

3 Sep 2010

Researchers develop gLQ Model to determine optimal dose level, treatment schedules for high-dose radiation therapies

There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers.Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute may have solved the problem by developing a new mathematical model that encompasses all dose levels.

3 Sep 2010

UB symposium to discuss in silico molecular design, high-throughput screening to treat diseases

Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept. 11 on "Twenty-first Century Bioscience: In Silico Methods and High-Throughput Screening," which will feature a variety of cutting-edge advances in the field developed by researchers in Western New York and throughout the US.

3 Sep 2010

ImmunoCellular Therapeutics updates accomplishments in Letter to Shareholders

As the summer comes to a close, I wanted to update you on the Company's accomplishments this year, which set the stage for an exciting fall. The first eight months of the year have been very successful, with the Company attaining many of its goals, despite a very difficult economic environment, which has created challenges for many small biotechnology companies. Today, IMUC is in its best financial position ever and well positioned to validate the success it achieved in a Phase I trial for ICT-107, its dendritic cell-based cancer vaccine product candidate.

3 Sep 2010

Virginia G. Piper Cancer Center at Scottsdale Healthcare offers free prostate cancer screenings

Recognizing that early detection can save lives, the Virginia G. Piper Cancer Center at Scottsdale Healthcare is offering free prostate cancer screenings from 8:30 a.m.-12 p.m. on Saturday, Sept. 11.

3 Sep 2010

Early marker for infants at higher-risk for autism may be infrequent gazing, study shows

Kennedy Krieger Institute announced today new study results showing an early marker for later communication and social delays in infants at a higher-risk for autism may be infrequent gazing at other people when unprompted. Published in the September issue of the Journal of Child Psychology and Psychiatry, the study also found that six-month-old high-risk infants demonstrated the same level of cause and effect learning skills when compared to low-risk infants of the same age.

3 Sep 2010

Governments called upon to recognize that access to pain management is a fundamental human right

Health care providers and researchers in the field of pain management are calling for governments worldwide to recognize the rights of people to the access of reasonable care for acute and chronic pain.

3 Sep 2010

ECRI Institute's 17th Annual Conference to be held October 19-20, at NIH

With the advent of healthcare reform, the United States is embarking on an unprecedented effort to determine which health care intervention works best for the diagnosis or treatment of a given disease or condition. While comparative effectiveness and personalized medicine evolved separately, these significant trends interface, increasingly, in the healthcare systems.

3 Sep 2010

Cancer News and Research

Latest Cancer News and Research

Childhood cancer survivors 5 times more likely to get cancer again: Study

New insight into abnormalities in cancer cells

Researchers to study protein fragments released into bloodstream after heart attack

Study suggest PET/CT scanning may offer effective breast cancer detection, spread

Genetic predisposition reduces breast, ovarian cancer risk with preventive surgeries: Study

MSKCC develops new prediction tool to calculate risk for DCIS recurrence after breast-conserving surgery

Exelixis grants 25,200 shares to nine new employees

Research on iPS cells can imply potential cell therapy for X-linked disorders

Researchers complete INX-189 clinical trials for Hepatitis C virus

CyberKnife radiosurgery treatment effective for prostate cancer without side effects

CSI Laboratories to expand new diagnostic laboratory in Alpharetta

Study finds acupuncture can control side effects of cancer treatment

More support needed for erectile dysfunction says sexologist

Researchers develop gLQ Model to determine optimal dose level, treatment schedules for high-dose radiation therapies

UB symposium to discuss in silico molecular design, high-throughput screening to treat diseases

ImmunoCellular Therapeutics updates accomplishments in Letter to Shareholders

Virginia G. Piper Cancer Center at Scottsdale Healthcare offers free prostate cancer screenings

Early marker for infants at higher-risk for autism may be infrequent gazing, study shows

Governments called upon to recognize that access to pain management is a fundamental human right

ECRI Institute's 17th Annual Conference to be held October 19-20, at NIH

Understanding the DNA Damage Response in Innate Immunity eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in